参考文献/References:
[1]GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators.Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021[J].Lancet Infect Dis,2024,24(9):974-1002.[2]Zheng Y,Qiu X,Wang T,et al.The Diagnostic Value of Metagenomic Next-Generation Sequencing in Lower Respiratory Tract Infection[J].Frontiers in Cellular and Infection Microbiology,2021,11:694756.[3]Zheng Y,Liu W,Xiao T,et al.Clinical utility of metagenomic next-generation sequencing on bronchoalveolar lavage fluid in diagnosis of lower respiratory tract infections[J].BMC pulmonary medicine,2024,24(1): 422.[4]中华医学会呼吸病学分会.中国成人社区获得性肺炎诊断和治疗指南(2016年版)[J].中华结核和呼吸杂志,2016,39(4):253-279..[5]Simner PJ,Miller S,Carroll KC.Understanding the Promises and Hurdles of Metagenomic Next-Generation Sequencing as a Diagnostic Tool for Infectious Diseases[J].Clin Infect Dis,2018,66(5):778-788.[6]Torres A,Cilloniz C,Niederman MS,et al.Pneumonia[J].Nature Reviews Disease Primers,2021,7(1):25.[7]File TM Jr,Ramirez JA.Community-Acquired Pneumonia[J].The New England Journal of Medicine,2023,389(7):632-641.[8]Diao Z,Han D,Zhang R,et al.Metagenomics next-generation sequencing tests take the stage in the diagnosis of lower respiratory tract infections[J].Journal of Advanced Research,2022,38:201-212.[9]Li H,Gao H,Meng H,et al.Detection of Pulmonary Infectious Pathogens From Lung Biopsy Tissues by Metagenomic Next-Generation Sequencing[J].Frontiers in Cellular and Infection Microbiology,2018,8:205.[10]Zhu YG,Tang XD,Lu YT,et al.Contemporary Situation of Community-acquired Pneumonia in China:A Systematic Review[J].Journal of Translational Internal Medicine,2018,6(1):26-31.[11]Liu Y,Ma Y.Clinical applications of metagenomics next-generation sequencing in infectious diseases[J].Journal of Zhejiang University Science B,2024,25(6):471-484.[12]Miao Q,Ma Y,Wang Q,et al.Microbiological Diagnostic Performance of Metagenomic Next-generation Sequencing When Applied to Clinical Practice[J].Clin Infect Dis,2018,67(suppl_2):S231-S240.[13]Shi Y,Chen J,Shi X,et al.A case of chlamydia psittaci caused severe pneumonia and meningitis diagnosed by metagenome next-generation sequencing and clinical analysis:a case report and literature review[J].BMC Infectious Diseases,2021,21(1):621.[14]Zhang Y,Wang W,Zhang Y,et al.Pulmonary Cryptococcosis Diagnosed by Metagenomic Next-Generation Sequencing in a Young Patient With Normal Immune Function:A Case Report[J].Frontiers in Public Health,2022,10:942282.[15]Li Y,Bian W,Wu S,et al.Metagenomic next-generation sequencing for Mycobacterium tuberculosis complex detection:a meta-analysis[J].Frontiers in Public Health,2023,11:1224993.[16]Sun H,Wang F,Zhang M,et al.Diagnostic Value of Bronchoalveolar Lavage Fluid Metagenomic Next-Generation Sequencing in Pneumocystis jirovecii Pneumonia in Non-HIV Immunosuppressed Patients[J].Frontiers in Cellular and Infection Microbiology,2022,12:872813.[17]Mostafa HH,Fissel JA,Fanelli B,et al.Metagenomic Next-Generation Sequencing of Nasopharyngeal Specimens Collected from Confirmed and Suspect COVID-19 Patients[J].mBio,2020,11(6):e01969-20.[18]胡贤珍,王亚飞,宋成,等.二代测序技术在社区获得性肺炎病原学诊断中的应用价值[J].数理医药学杂志,2023,36(4):261-266.[19]Han D,Yu F,Zhang D,et al.Applicability of Bronchoalveolar Lavage Fluid and Plasma Metagenomic Next-Generation Sequencing Assays in the Diagnosis of Pneumonia[J].Open Forum Infectious Diseases,2024,11(1):ofad631.[20]Chen S,Kang Y,Li D,et al.Diagnostic performance of metagenomic next-generation sequencing for the detection of pathogens in bronchoalveolar lavage fluid in patients with pulmonary infections:Systematic review and meta-analysis[J].International Journal of Infectious Diseases,2022,122:867-873.(Electronic).[21]Zhan W,Liu Q,Yang C,et al.Evaluation of metagenomic next-generation sequencing diagnosis for invasive pulmonary aspergillosis in immunocompromised and immunocompetent patients[J].Mycoses,2023,66(4):331-337.[22]Ekeng BE,Davies AA,Osaigbovo II,et al.Pulmonary and Extrapulmonary Manifestations of Fungal Infections Misdiagnosed as Tuberculosis:The Need for Prompt Diagnosis and Management[J].Journal of Fungi (Basel,Switzerland),2022,8(5):460.
相似文献/References:
[1]赵建美,邵 岩.血必净治疗社区获得性肺炎的研究进展[J].医学信息,2018,31(02):20.[doi:10.3969/j.issn.1006-1959.2018.02.009]
ZHAO Jian-mei,SHAO Yan.Research Progress of Xuebijing in Treating Community Acquired Pneumonia[J].Journal of Medical Information,2018,31(18):20.[doi:10.3969/j.issn.1006-1959.2018.02.009]
[2]包克珍,许云丽.新生儿社区获得性肺炎的临床特征分析[J].医学信息,2018,31(02):184.[doi:10.3969/j.issn.1006-1959.2018.02.072]
BAO Ke-zhen,XU Yun-li.Clinical Characteristics of Neonatal Community Acquired Pneumonia[J].Journal of Medical Information,2018,31(18):184.[doi:10.3969/j.issn.1006-1959.2018.02.072]
[3]赵建美,邵 岩,李京津.电脑中频药透对治疗老年社区获得性肺炎的疗效分析[J].医学信息,2018,31(03):146.[doi:10.3969/j.issn.1006-1959.2018.03.052]
ZHAO Jian-mei,SHAO Yan,LI Jing-jin.Analysis of the Efficacy of Computer Medium Frequency Drug Penetration in the Treatment of Elderly Community-acquired Pneumonia[J].Journal of Medical Information,2018,31(18):146.[doi:10.3969/j.issn.1006-1959.2018.03.052]
[4]曹立杰,杨林瀛,于国云,等.N-末端脑钠肽前体与社区获得性肺炎患者严重程度关系研究[J].医学信息,2018,31(04):1.[doi:10.3969/j.issn.1006-1959.2018.04.001]
CAO Li-jie,YANG Lin-ying,YU Guo-yun,et al.Study on the Relationship between N-terminal Brain Natriuretic Peptide Precursors and the Severity of Community-acquired Pneumonia[J].Journal of Medical Information,2018,31(18):1.[doi:10.3969/j.issn.1006-1959.2018.04.001]
[5]俞 静,赵 红,金 晶,等.社区获得性肺炎胸部CT中反晕征的初步研究[J].医学信息,2022,35(10):109.[doi:10.3969/j.issn.1006-1959.2022.10.026]
YU Jing,ZHAO Hong,JIN Jing,et al.Preliminary Study of Reversed Halo Sign in Chest CT of Community-acquired Pneumonia[J].Journal of Medical Information,2022,35(18):109.[doi:10.3969/j.issn.1006-1959.2022.10.026]
[6]武珊珊.喜炎平注射液治疗社区获得性肺炎临床疗效的Meta分析[J].医学信息,2018,31(14):64.[doi:10.3969/j.issn.1006-1959.2018.14.020]
WU Shan-shan.Meta-analysis of Clinical Efficacy of Xiyanping Injection in the Treatment of
Community-acquired Pneumonia[J].Journal of Medical Information,2018,31(18):64.[doi:10.3969/j.issn.1006-1959.2018.14.020]
[7]徐安林,刘 忠.不同配比的哌拉西林-他唑巴坦治疗
老年性社区获得性肺炎的疗效对比[J].医学信息,2018,31(15):129.[doi:10.3969/j.issn.1006-1959.2018.15.041]
XU An-lin,LIU Zhong.Comparison of the Efficacy of Different Ratios of Piperacillin-tazobactam in Elderly Community Acquired Pneumoni[J].Journal of Medical Information,2018,31(18):129.[doi:10.3969/j.issn.1006-1959.2018.15.041]
[8]许 俊.慢性阻塞性肺疾病急性加重期与慢性阻塞性肺疾病并发社区获得性肺炎患者的临床对比[J].医学信息,2018,31(22):118.[doi:10.3969/j.issn.1006-1959.2018.22.033]
XU Jun.Clinical Comparison of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Chronic Obstructive Pulmonary Disease Complicated with Community Acquired Pneumonia[J].Journal of Medical Information,2018,31(18):118.[doi:10.3969/j.issn.1006-1959.2018.22.033]
[9]远 颖.成人社区获得性肺炎中医药研究[J].医学信息,2018,31(23):55.[doi:10.3969/j.issn.1006-1959.2018.23.016]
YUAN Ying.Traditional Chinese Medicine Research on Adult Community Acquired Pneumonia[J].Journal of Medical Information,2018,31(18):55.[doi:10.3969/j.issn.1006-1959.2018.23.016]
[10]陈亚南,陈 赛,毛琦善.青壮年与中老年社区获得性肺炎病原体的对比分析[J].医学信息,2019,32(01):145.[doi:10.3969/j.issn.1006-1959.2019.01.045]
CHEN Ya-nan,CHEN Sai,MAO Qi-shan.Comparative Analysis of Pathogens of Acquired Pneumonia among Young Adults and Middle-aged and Elderly People[J].Journal of Medical Information,2019,32(18):145.[doi:10.3969/j.issn.1006-1959.2019.01.045]